Results 11 to 20 of about 240,962 (71)

Localization of lanthanum in bone of chronic renal failure rats after oral dosing with lanthanum carbonate [PDF]

, 2005
Background. Lanthanum carbonate has been shown to be a safe, effective phosphate-binding agent. We have shown that an impaired mineralization in chronic renal failure rats treated with high doses of lanthanum carbonate develops secondary to phosphate ...
Behets, Geert J., Bervoets, An R., D'Haese, Patrick C., Denton, John, Cox, Alan G., Salomé, Murielle, De Broe, Marc E., Verberckmoes, Steven C., Oste, Line   +8 more
core   +12 more sources

Crystal structure and spectral characterization of La2(CO3)3 ⋅ 5H2O – an industrially relevant lanthanide carbonate

Zeitschrift für anorganische und allgemeine Chemie, Volume 648, Issue 23, December 13, 2022., 2022
Abstract The conversion of La2O3 with HCl, subsequent neutralization and precipitation using (NH4)2CO3 in an industrial process leads to the previously unknown La2(CO3)3 ⋅ 5H2O. The phase was characterized by X‐ray powder diffraction leading to an averaged crystal structure model, thermal analysis, vibrational and optical spectroscopy. La2(CO3)3 ⋅ 5H2O
Esengül Çiftçi, Filip Podjaski, Andreas Gouder, Bettina V. Lotsch, Robert E. Dinnebier, Sebastian Bette   +5 more
wiley   +1 more source

Hollow Structured Transition Metal Phosphates and Their Applications

The Chemical Record, Volume 22, Issue 8, August 2022., 2022
Design and synthesis of hollow transition metal phosphate for catalysis, energy conversion and bio‐application. Abstract Hollow nanostructures of transition metal phosphate are of immense interest in the existing and evolving areas of technology, due to their high surface area, presence of hollow void, and easy tuning of compositions and dimensions ...
Samira Munkaila, Rabin Dahal, Manzili Kokayi, Tatyana Jackson, Bishnu Prasad Bastakoti   +4 more
wiley   +1 more source

Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden

, 2008
BACKGROUND: Despite recognized risks associated with hyperphosphataemia in patients with chronic kidney disease (CKD) Stage 5 on dialysis, the achievement of target levels of serum phosphate is poor. It is likely that this is partly due to poor adherence
LAVILLE M, HUTCHISON AJ, ALBERTAZZI, Alberto, SPD LANTHANUM STUDY GROUP   +3 more
core   +2 more sources

Lanthanum Carbonate Opacities—A Systematic Review [PDF]

, 2022
Background: Lanthanum carbonate is a phosphate binder used in advanced kidney disease. Its radiopaque appearance has been described in many case studies and case series.
Andreas Hjelm Brandt, Kampmann, Jan, Nina Pirschel Hansen, Hansen, Nina Pirschel, Brandt, Frans, Anders Nikolai Ørsted Schultz, Jan Kampmann, Schultz, Anders Nikolai Ørsted; id_orcid, Brandt, Andreas Hjelm, Frans Brandt   +9 more
core   +1 more source

The Effect of Rare Earth Elements on Growth Performance, Tibia Mineralization and Blood Serum of Japanese Quails. [PDF]

, 2007
The present study was designed to determine the effect of different types and concentrations rare earth elements on growth performance of Japanese quails.
Zohravi, Maryam
core   +1 more source

Lanthanum carbonate oral powder: satisfaction, preference and adherence in French and Spanish patients with end-stage renal disease

, 2016
Background: Phosphate binders, such as lanthanum carbonate, control elevated serum-phosphate levels in patients with end-stage renal disease (ESRD). Lanthanum carbonate is available in oral powder and tablet form.
Patricia de Sequera, Michael Keith, Riccardo Pedersini, Francois Clair   +3 more
core   +1 more source

The effect of lanthanum addition on the catalytic activity of γ-alumina supported bimetallic Co–Mo carbides for dry methane reforming [PDF]

, 2014
The effect of lanthanum addition to γ-alumina supported bimetallic carbides has been studied for the reaction of dry methane reforming using four different lanthanum loading levels of 1, 5, 10 and 15 wt% of lanthanum.
Liam J. France, Vladimir L. Kuznetsov, Edwards, Peter P., Naif Almuqati, Abdulaziz Bagabas, Jiang Zheng, Tiancun Xiao, Du, Xian, Xian Du, Hamid Almegren, Jiang, Zheng, Almuqati, Naif, Yongxiang Zhao, Peter P. Edwards, Kuznetsov, Vladimir L., Xiao, Tiancun, Almegren, Hamid, Bagabas, Abdulaziz, Zhao, Yongxiang, France, Liam J   +19 more
core   +2 more sources

Measurement of serum lanthanum in patients treated with lanthanum carbonate by inductively coupled plasma-mass spectrometry

, 2011
Background Lanthanum carbonate is used as a phosphate binder in patients with stage V chronic kidney disease (CKD). While well tolerated in clinical trials, with no toxicity reported as regards bone and liver metabolism, and cognitive function, concerns ...
K B Raja, R J Flanagan, Raja, K B, Flanagan, R J, Sharpe, C, C Sharpe, S A Handley, Handley, S A   +7 more
core   +2 more sources

Lanthanum carbonate

, 2006
Controlling hyperphosphatemia in patients with chronic renal failure on renal dialysis is a major problem. None of the available calcium- or aluminum-based phosphate binders match the requirements for an ideal agent, each having its own limitations.
Freemont, A. J.; id_orcid, Freemont, A.J.   +1 more
core   +1 more source